Ipca Laboratories Ltd
🇰🇪Kenya
- Country
- 🇰🇪Kenya
- Ownership
- Public
- Established
- 1949-01-01
- Employees
- 22.8K
- Market Cap
- $4.2B
- Website
- http://www.ipca.com
Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition
- First Posted Date
- 2012-06-13
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01618760
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-06-13
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT01618799
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2012-07-09
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT01603186
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT01603173
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT01603134
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-16
- Last Posted Date
- 2012-07-09
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT01577914
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-16
- Last Posted Date
- 2012-04-16
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01578252
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-16
- Last Posted Date
- 2012-04-16
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01578265
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-03-30
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT01567501
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT01557439
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
© Copyright 2024. All Rights Reserved by MedPath